MicroRNA-28 replacement for non-Hodgkin lymphoma therapy

SRP074600

Homo sapiens

12 Downloadable Samples

Illumina HiSeq 2500

Submitter Supplied Information

Description

Our studies identify the role of mIR-28 in germinal center response and its therapeutic potential for the treatment of non-Hodgkin lymphomas Overall design: The effect of miR-28 expression in the transcriptome was analyzed in Ramos Burkitt B cells by RNASeq.

PubMed ID

28188132

Publication Title

miR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma.

Total Samples

Submitter’s Institution

No associated institution

Authors

Bartolomé-Izquierdo N, de Yébenes VG, Álvarez-Prado AF, Mur SM, Lopez Del Olmo JA, Roa S, Vazquez J, Ramiro AR

Source Repository

Sequence Read Archive (SRA)

No rows found